Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu
Education
  • 2016 Çocuk Nefrolojisi ve Romatolojisi Professorü
  • 2011 Tıpta Uzmanlık Kurulu Çocuk Romatolojisi
  • 2004 Çocuk Nefrolojisi Associate Professori
  • 1999 Ankara Dr.Sami Ulus Kadın Doğum Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hospital Çocuk Nefrolojisi
  • 1993 Ankara Dr.Sami Ulus Kadın Doğum Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hospital Çocuk Sağlığı ve Hastalıkları
  • 1988 Hacettepe University Faculty of Medicine
Experience
  • 2025 Acıbadem Healthcare Services
  • 2016 - 2022 Çocuk Nefrolojisi ve Romatolojisi Bölüm Başkanlığı, Ondokuz Mayıs University Faculty of Medicine 2022-2024: Bahçelievler Medical Park Hospital
  • 2011 - 2016 Çocuk Nefrolojisi ve Romatolojisi Kliniği Eğitim Sorumlusu
  • 1008 - 2011 Çocuk Nefrolojisi Şef Yardımcılığı, Ankara Dr. Sami Ulus Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hospital
  • 1999 - 2008 Çocuk Nefrolojisi Uzmanlığı, Ankara Dr. Sami Ulus Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hospital
  • 1995 - 1999 Çocuk Nefrolojisi Araştırma Görevlisi, Ankara Dr. Sami Ulus Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hospital
  • 1993 - 1995 Pediatri Chief Assistantlığı, Ankara Dr. Sami Ulus Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hospital
  • 1988 - 1993 Pediatri Araştırma Görevlisi, Ankara Dr. Sami Ulus Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hospital
Memberships
  • Milli Pediatri Association
  • Çocuk Nefroloji Association
  • Çocuk Romatoloji Association
  • Türk Nefroloji Association
PUBLICATIONS
  • Complement gene mutations in children with C3 glomerulopathy: do they affect the response to mycophenolate mofetil? 2024 May;39(5): 1435-1446. doi: 10.1007/s00467-023-06231-2. Epub 2023 Dec 2. Özlem Aydoğ 5, Bahriye Atmış15, Aysun Çaltık Yılmaz16, Sevcan A Bakkaloğlu17, Mehmet Baha Aytaç18, Mehmet Taşdemir19, Belde Kasap Demir20
  • Urine soluble TLR4 levels may contribute to predict urinary tract infection in children: the UTILISE Study. Pediatr Nephrol. 2024 Feb;39(2):483-491. doi: 10.1007/S00467-023-06063-0. Epub 2023 Jul 18.PMID: 37462743 Aksu B, Afonso AC, Akil I, Alpay H, Atmis B, Aydog O, Bayazıt AK, Bayram MT, Bilge I,
  • Case report: Thrombötic microangiopathy in pediatric multisystem inflammatory syndrome associated with COVID- 19: a case series Front Pediatr. 2023 Oct 12:11:1254308. doi: 10.3389/fped.2023.1254308. eCollection 2023. Hülya Nalçacıoğlu1, H Gözde Önal1, Burcu Bozkaya Yücel2, Demet Tekcan Karali1, Emine Erdeniz3, Gökçen Öz Tuncer4, Özlem Aydoğ
  • Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study Joint Bone Spine. 2023 Jul;90(4):105559. doi: 10.1016/j.jbspin.2023.105559. Epub 2023 Feb 28.PMID: 36858168. Aydoğ Ö, Aksu G, Akman S, Dönmez O, Bülbül M, Büyükçelik M, Tabel Y, Sözeri B, Kalyoncu M, Bilginer Y,
  • Urinary HSP70 improves diagnostic accuracy for urinary tract infection in children: UTILISE study. Pediatr Nephrol. 2023 Mar;38(3):791-799. doi: 10.1007/s00467-022-05664-5. Epub 2022 Jul 18.PMID: 35849222 Yilmaz A, Afonso AC, Akil I, Aksu B, Alpay H, Atmis B, Aydoğ O, Bayazıt AK, Bayram MT, Bilge I, Bulut IK, Buyukkaragoz B, Çomak E, Demir BK, Dincel
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""